CSBR
CHAMPIONS ONCOLOGY, INC.
NASDAQ · Healthcare · Biotechnology · US
$4.69
−0.21%Forward multiples
Based on analyst estimates
- P/E forward
- 42.64x
- P/E 2026E
- 47.35x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 16.77x
- Price / sales
- 1.08x
- Price / cash flow
- -11.73x
Enterprise value
- Enterprise value
- $72.5M
- EV / sales
- 1.19x
- EV / EBITDA
- 162.10x
- EV / EBIT
- -69.54x
- Market cap
- $65.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026